Predicting all-cause mortality by means of a multisensor implantable defibrillator algorithm for heart failure monitoring

被引:4
作者
D'Onofrio, Antonio [1 ]
Vitulano, Gennaro [2 ]
Calo, Leonardo [3 ]
Bertini, Matteo [4 ]
Santini, Luca [5 ]
Savarese, Gianluca [6 ]
Dello Russo, Antonio [7 ]
Santobuono, Vincenzo Ezio [8 ]
Lavalle, Carlo [9 ]
Viscusi, Miguel [10 ]
Amellone, Claudia [11 ]
Calvanese, Raimondo [12 ]
Santoro, Amato [13 ]
Ziacchi, Matteo [14 ]
Palmisano, Pietro [15 ]
Pisano, Ennio [16 ]
Bianchi, Valter [1 ]
Tavoletta, Vincenzo [1 ]
Campari, Monica [17 ]
Valsecchi, Sergio [17 ]
Boriani, Giuseppe [18 ]
机构
[1] Monaldi Hosp, Unita Operat Elettrofisiol Studio & Terapia Aritmi, Via Leonardo Bianchi 1, I-80131 Naples, Italy
[2] OORR San Giovanni Dio Ruggi Aragona, Salerno, Italy
[3] Policlin Casilino, Rome, Italy
[4] Univ Ferrara, S Anna Univ Hosp, Ferrara, Italy
[5] Giovan Battista Grassi Hosp, Rome, Italy
[6] S Giovanni Battista Hosp, Foligno, Italy
[7] Univ Politecn Marche, Osped Riuniti, Ancona, Italy
[8] Univ Bari, Policlin Bari, Bari, Italy
[9] Policlin Umberto 1, Rome, Italy
[10] S Anna & S Sebastiano Hosp, Caserta, Italy
[11] Maria Vittoria Hosp, Turin, Italy
[12] ASL NA1, Osped Mare, Naples, Italy
[13] AOU Senese, Siena, Italy
[14] Univ Bologna, S Orsola Malpighi Univ Hosp, Bologna, Italy
[15] G Panico Hosp, Tricase, LE, Italy
[16] Vito Fazzi Hosp, Lecce, Italy
[17] Boston Sci Italia, Milan, Italy
[18] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Cardiol Div, Policlin Modena, Modena, Italy
关键词
Cardiac resynchronization therapy; Death; Heart Fail-ure; Implantable cardioverter-defibrillator; Remote monitoring; Risk stratification; BRAIN NATRIURETIC PEPTIDE; CARDIOVERTER-DEFIBRILLATOR; RISK SCORES; DEVICES; TIME; HF;
D O I
10.1016/j.hrthm.2023.03.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The HeartLogic algorithm (Boston Scientific) has proved to be a sensitive and timely predictor of impending heart failure (HF) decompensation. OBJECTIVE The purpose of this study was to determine whether remotely monitored data from this algorithm could be used to iden-tify patients at high risk for mortality. METHODS The algorithm combines implantable cardioverter-defibrillator (ICD)-measured accelerometer-based heart sounds, intrathoracic impedance, respiration rate, ratio of respiration rate to tidal volume, night heart rate, and patient activity into a single index. An alert is issued when the index crosses a programmable threshold. The feature was activated in 568 ICD patients from 26 centers. RESULTS During median follow-up of 26 months [25th-75th percentile 16-37], 1200 alerts were recorded in 370 patients (65%). Overall, the time IN-alert state was 13% of the total obser-vation period (151/1159 years) and 20% of the follow-up period of the 370 patients with alerts. During follow-up, 55 patients died (46 in the group with alerts). The rate of death was 0.25 per patient-year (95% confidence interval [CI] 0.17-0.34) IN-alert state and 0.02 per patient-year (95% CI 0.01-0.03) OUT of the alert state, with an incidence rate ratio of 13.72 (95% CI 7.62-25.60; P <.001). After multivariate correction for baseline confounders (age, ischemic cardiomyopathy, kidney disease, atrial fibrillation), the IN-alert state remained significantly associated with the occur-rence of death (hazard ratio 9.18; 95% CI 5.27-15.99; P <.001). CONCLUSION The HeartLogic algorithm provides an index that can be used to identify patients at higher risk for all-cause mortality. The index state identifies periods of significantly increased risk of death.
引用
收藏
页码:992 / 997
页数:6
相关论文
共 50 条
  • [31] Association between amount of biventricular pacing and heart failure status measured by a multisensor implantable de fi brillator algorithm
    Santini, Luca
    Calo, Leonardo
    D'Onofrio, Antonio
    Manzo, Michele
    Dello Russo, Antonio
    Savarese, Gianluca
    Pecora, Domenico
    Amellone, Claudia
    Santobuono, Vincenzo Ezio
    Calvanese, Raimondo
    Viscusi, Miguel
    Pisano, Ennio
    Pangallo, Antonio
    Rapacciuolo, Antonio
    Bertini, Matteo
    Lavalle, Carlo
    Santoro, Amato
    Campari, Monica
    Valsecchi, Sergio
    Boriani, Giuseppe
    [J]. CARDIOVASCULAR DIGITAL HEALTH JOURNAL, 2024, 5 (03): : 164 - 172
  • [32] Associations of Heart Failure Onset Age with All-Cause Mortality: The Kailuan Study
    Li, Wei
    Gao, Haibo
    Zhao, Xuemei
    Wang, Yifei
    Yang, Jing
    Zheng, Hongwei
    Wang, Liyan
    Wu, Shouling
    Zhang, Qi
    [J]. CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2024, 9 (01) : 1 - 9
  • [33] Telomere length is independently associated with all-cause mortality in chronic heart failure
    Romaine, Simon P. R.
    Denniff, Matthew
    Codd, Veryan
    Nath, Mintu
    Koekemoer, Andrea
    Anker, Stefan D.
    Cleland, John G.
    Filippatos, Gerasimos
    Levin, Daniel
    Metra, Marco
    Mordi, Ify R.
    Ouwerkerk, Wouter
    ter Maaten, Jozine M.
    van Veldhuisen, Dirk J.
    Zannad, Faiez
    Ng, Leong L.
    van der Harst, Pim
    Lang, Chim C.
    Voors, Adriaan A.
    Nelson, Christopher P.
    Samani, Nilesh J.
    [J]. HEART, 2022, 108 (02) : 124 - 129
  • [34] Impact of Baseline Heart Failure Burden on Post-Implantable Cardioverter-Defibrillator Mortality Among Medicare Beneficiaries
    Chen, Chih-Ying
    Stevenson, Lynne Warner
    Stewart, Garrick C.
    Seeger, John D.
    Williams, Lauren
    Jalbert, Jessica J.
    Setoguchi, Soko
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (21) : 2142 - 2150
  • [35] Absence of Obesity Paradox in All-Cause Mortality Among Chinese Patients With an Implantable Cardioverter Defibrillator: A Multicenter Cohort Study
    Zhou, Bin
    Sun, Xuerong
    Yu, Na
    Zhao, Shuang
    Chen, Keping
    Hua, Wei
    Su, Yangang
    Yang, Jiefu
    Liang, Zhaoguang
    Xu, Wei
    Tang, Min
    Zhang, Shu
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [36] Association of Implantable Cardioverter Defibrillator Therapy with All-Cause MortalityA Systematic Review and Meta-Analysis
    Qian, Zhiyong
    Zhang, Zhiyong
    Guo, Jianghong
    Wang, Yao
    Hou, Xiaofeng
    Feng, Guangzhi
    Zou, Jiangang
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2016, 39 (01): : 81 - 88
  • [37] Impact of a Telehealth and Care Management Program on All-Cause Mortality and Healthcare Utilization in Patients with Heart Failure
    Kao, David P.
    Lindenfeld, Joann
    Macaulay, Dendy
    Birnbaum, Howard G.
    Jarvis, John L.
    Desai, Urvi S.
    Page, Robert L., II
    [J]. TELEMEDICINE AND E-HEALTH, 2016, 22 (01) : 2 - 11
  • [38] Prediction of worsening heart failure events and all-cause mortality using an individualized risk stratification strategy
    Zile, Michael R.
    Koehler, Jodi
    Sarkar, Shantanu
    Butler, Javed
    [J]. ESC HEART FAILURE, 2020, 7 (06): : 4277 - 4289
  • [39] Nomogram for predicting 30-day all-cause mortality after transvenous pacemaker and defibrillator lead extraction
    Brunner, Michael P.
    Yu, Changhong
    Hussein, Ayman A.
    Tarakji, Khaldoun G.
    Wazni, Oussama M.
    Kattan, Michael W.
    Wilkoff, Bruce L.
    [J]. HEART RHYTHM, 2015, 12 (12) : 2381 - 2386
  • [40] Galectin-3 in heart failure: high levels are associated with all-cause mortality
    Ueland, Thor
    Aukrust, Pal
    Broch, Kaspar
    Aakhus, Svend
    Skardal, Rita
    Muntendam, Pieter
    Gullestad, Lars
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (03) : 361 - 364